• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活剂uPA和tPA对肝细胞生长因子的激活作用。

Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

作者信息

Mars W M, Zarnegar R, Michalopoulos G K

机构信息

Department of Pathology, University of Pittsburgh, Pennsylvania 15261.

出版信息

Am J Pathol. 1993 Sep;143(3):949-58.

PMID:8362987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1887222/
Abstract

Hepatocyte growth factor, also known as scatter factor, is a complete mitogen for hepatocytes that bears sequence and structural homology with plasminogen. Because it exists in both a mitogenically inactive single-chain form and an active two-chain form, we were interested in determining whether plasminogen activators could properly cleave single-chain hepatocyte growth factor to generate active two-chain hepatocyte growth factor. Herein we report that both urokinase-type plasminogen activator and tissue-type plasminogen activator can cleave single-chain hepatocyte growth factor, generating two-chain hepatocyte growth factor. When equal quantities of plasminogen activator-treated and activator-untreated hepatocyte growth factor are compared in serum-free in vitro bioassays, the treated hepatocyte growth factor is mitotically more active. Also, urokinase-type plasminogen activator was inactive against hepatocyte growth factor molecules with a mutated cleavage site. This suggests that urokinase-type and tissue-type plasminogen activator may be natural biological regulators of hepatocyte growth factor. Because the active form of hepatocyte growth factor is a powerful stimulator of DNA synthesis and cell motility, these findings may be relevant in understanding the role of plasminogen activators in the biology of cancer invasion and metastasis.

摘要

肝细胞生长因子,也称为分散因子,是一种对肝细胞具有完全促有丝分裂作用的因子,它与纤溶酶原在序列和结构上具有同源性。由于它以有丝分裂无活性的单链形式和活性双链形式存在,我们有兴趣确定纤溶酶原激活剂是否能正确切割单链肝细胞生长因子以产生活性双链肝细胞生长因子。在此我们报告,尿激酶型纤溶酶原激活剂和组织型纤溶酶原激活剂都能切割单链肝细胞生长因子,产生双链肝细胞生长因子。在无血清体外生物测定中比较等量的经纤溶酶原激活剂处理和未处理的肝细胞生长因子时,经处理的肝细胞生长因子在有丝分裂方面更具活性。此外,尿激酶型纤溶酶原激活剂对具有突变切割位点的肝细胞生长因子分子无活性。这表明尿激酶型和组织型纤溶酶原激活剂可能是肝细胞生长因子的天然生物调节剂。由于肝细胞生长因子的活性形式是DNA合成和细胞运动的强大刺激剂,这些发现可能与理解纤溶酶原激活剂在癌症侵袭和转移生物学中的作用有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/881a1b2fd629/amjpathol00069-0313-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/781a437850d7/amjpathol00069-0309-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/64b95594414c/amjpathol00069-0310-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/75331bf2d492/amjpathol00069-0311-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/52be54f7384a/amjpathol00069-0313-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/881a1b2fd629/amjpathol00069-0313-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/781a437850d7/amjpathol00069-0309-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/64b95594414c/amjpathol00069-0310-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/75331bf2d492/amjpathol00069-0311-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/52be54f7384a/amjpathol00069-0313-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/1887222/881a1b2fd629/amjpathol00069-0313-b.jpg

相似文献

1
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.纤溶酶原激活剂uPA和tPA对肝细胞生长因子的激活作用。
Am J Pathol. 1993 Sep;143(3):949-58.
2
Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.无血清原代大鼠肝细胞培养物中尿激酶的存在及其在激活肝细胞生长因子中的作用。
Cancer Res. 1996 Jun 15;56(12):2837-43.
3
Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.组织型纤溶酶原激活剂缺乏会加重小鼠的胆汁淤积性肝损伤。
Hepatology. 2007 Jun;45(6):1527-37. doi: 10.1002/hep.21613.
4
HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.肝细胞癌、纤维板层样变体、肝硬化和正常肝脏中的肝细胞生长因子、间质-上皮转化因子及基质相关蛋白酶
Mod Pathol. 2003 Jan;16(1):14-21. doi: 10.1097/01.MP.0000043521.96995.DB.
5
Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.尿激酶型纤溶酶原激活剂/尿激酶型纤溶酶原激活剂受体系统的激活以及E-钙黏蛋白的重新分布与肝细胞生长因子诱导的过表达Met的胰腺肿瘤细胞的迁移有关。
Am J Pathol. 1998 Jul;153(1):201-12. doi: 10.1016/S0002-9440(10)65561-7.
6
The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.格尔德霉素是肝细胞生长因子/分散因子-甲硫氨酸-尿激酶型纤溶酶原激活剂-纤溶酶蛋白水解网络的强效抑制剂。
Cancer Res. 2000 Jan 15;60(2):342-9.
7
Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration.部分肝切除术后尿激酶受体的早期检测及其对肝再生启动的影响。
Hepatology. 1995 Jun;21(6):1695-701.
8
Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.组织型纤溶酶原激活剂对于血小板衍生生长因子-C的激活并非必需。
Biochim Biophys Acta. 2014 Feb;1842(2):318-25. doi: 10.1016/j.bbadis.2013.11.013. Epub 2013 Nov 19.
9
Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.尿激酶型纤溶酶原激活剂对肝细胞生长因子的激活作用依赖于离子强度。
Biochem J. 2005 Aug 15;390(Pt 1):311-5. doi: 10.1042/BJ20042028.
10
Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.转化生长因子β抑制大鼠成骨样细胞中的纤溶酶原激活物(PA)活性,并刺激尿激酶型PA、PA抑制剂-1 mRNA及蛋白的产生。
J Cell Physiol. 1991 Oct;149(1):34-43. doi: 10.1002/jcp.1041490106.

引用本文的文献

1
Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism.两个系统的故事:纤溶与脂蛋白代谢的交织双重性。
J Thromb Haemost. 2023 Oct;21(10):2679-2696. doi: 10.1016/j.jtha.2023.08.004. Epub 2023 Aug 12.
2
Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection.与术前血浆水平相比,微创结直肠切除术后尿激酶型纤溶酶原激活物-1水平在6周内持续升高。
J Gastrointest Oncol. 2023 Feb 28;14(1):187-197. doi: 10.21037/jgo-22-113. Epub 2023 Feb 13.
3
MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities.

本文引用的文献

1
Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation.用于确定暴露于电离辐射的实质肝细胞克隆形成存活率的移植系统。
Cancer Res. 1981 Sep;41(9 Pt 1):3512-8.
2
Partial characterization of a hepatocyte growth factor from rat platelets.大鼠血小板中肝细胞生长因子的部分特性分析。
J Cell Physiol. 1984 May;119(2):183-92. doi: 10.1002/jcp.1041190207.
3
Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.从肝切除大鼠血清中部分纯化和鉴定肝细胞生长因子
MET扩增作为肺癌中TKI治疗的耐药驱动因素:临床挑战与机遇
Cancers (Basel). 2023 Jan 18;15(3):612. doi: 10.3390/cancers15030612.
4
Role of the Hippo pathway in liver regeneration and repair: recent advances.河马通路在肝脏再生与修复中的作用:最新进展
Inflamm Regen. 2022 Dec 5;42(1):59. doi: 10.1186/s41232-022-00235-5.
5
Fibroadipogenic Progenitors Regulate the Basal Proliferation of Satellite Cells and Homeostasis of Pharyngeal Muscles via HGF Secretion.纤维脂肪生成祖细胞通过分泌肝细胞生长因子调节卫星细胞的基础增殖和咽肌的稳态。
Front Cell Dev Biol. 2022 May 17;10:875209. doi: 10.3389/fcell.2022.875209. eCollection 2022.
6
Hepatocyte Growth Factor-Dependent Antiviral Activity of Activated cdc42-Associated Kinase 1 Against Hepatitis B Virus.活化的cdc42相关激酶1对乙型肝炎病毒的肝细胞生长因子依赖性抗病毒活性
Front Microbiol. 2021 Dec 23;12:800935. doi: 10.3389/fmicb.2021.800935. eCollection 2021.
7
Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival.双链组织型纤溶酶原激活物统一代谢型谷氨酸受体和 NMDA 受体信号转导以控制神经元存活。
Int J Mol Sci. 2021 Dec 15;22(24):13483. doi: 10.3390/ijms222413483.
8
Preferable Transplant Site for Hepatocyte Transplantation in a Rat Model.肝源细胞移植在大鼠模型中的首选移植部位。
Cell Transplant. 2021 Jan-Dec;30:9636897211040012. doi: 10.1177/09636897211040012.
9
Critical Role of LSEC in Post-Hepatectomy Liver Regeneration and Failure.LSEC 在肝切除术后肝再生和衰竭中的关键作用。
Int J Mol Sci. 2021 Jul 28;22(15):8053. doi: 10.3390/ijms22158053.
10
Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury.神经创伤中的丝氨酸蛋白酶和趋化因子:脊髓损伤中免疫调节治疗的新靶点。
Curr Neuropharmacol. 2021;19(11):1835-1854. doi: 10.2174/1570159X19666210225154835.
Biochem Biophys Res Commun. 1984 Aug 16;122(3):1450-9. doi: 10.1016/0006-291x(84)91253-1.
4
On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.论纤维蛋白溶解的调控。爱德华·科瓦尔斯基纪念讲座。
Thromb Haemost. 1980 Jun 18;43(2):77-89.
5
Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein.在含有纤溶酶原和酪蛋白的SDS-聚丙烯酰胺凝胶中对人和猪纤溶酶原激活剂进行比较电泳分析。
Biochim Biophys Acta. 1983 May 30;745(1):82-9. doi: 10.1016/0167-4838(83)90172-3.
6
Control of hepatocyte replication by two serum factors.两种血清因子对肝细胞复制的调控
Cancer Res. 1984 Oct;44(10):4414-9.
7
Biological control of tissue plasminogen activator-mediated fibrinolysis.组织型纤溶酶原激活剂介导的纤维蛋白溶解的生物控制。
Enzyme. 1988;40(2-3):130-43. doi: 10.1159/000469155.
8
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility.分散因子是一种由成纤维细胞产生的上皮细胞迁移调节因子。
Nature. 1987;327(6119):239-42. doi: 10.1038/327239a0.
9
Molecular cloning and expression of human hepatocyte growth factor.人肝细胞生长因子的分子克隆与表达
Nature. 1989 Nov 23;342(6248):440-3. doi: 10.1038/342440a0.
10
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor.人肝细胞生长因子cDNA的分子克隆及序列分析
Biochem Biophys Res Commun. 1989 Sep 15;163(2):967-73. doi: 10.1016/0006-291x(89)92316-4.